BILLS-109hr5641ih.pdf

22:45 Jun 21, 2006 5641 VerDate Aug 31 2005 22 year June 10, 2004 20 1979 JUNE 20, 2006 June 15, 2006 June 2004 April 30, 2001 31 2005 September 2001 21

SESSION H. R. 5641 the ‘‘Safe Overseas Human 4

PO 00000 Frm 00006 PO 00000 Frm PO 00000 Frm 00010 PO 00000 Frm 00009 PO 00000 Frm 00008 Fmt PO 00000 Frm 00004 PO 00000 Frm 00007 PO 00000 Frm 00011 Fmt PO 00000 Frm 00001

United States the United States Helsinki the United States of America Ohio

Insti-

FDA the Federal Food, Drug SEC NBAC Senate uct Federal Regulations Federal, State Food, Drug Federal Human Services IRB National Bioethics the Committee on International the Department of Health the Inspector General CONGRESS House of Representa- Review Board the Committee on International Relations Health Organization THE HOUSE OF REPRESENTATIVES Institutional Review Boards the Office of the In- KETING the Export Administration Act the Food and Drug

LANTOS mary BROWN

trials fda clinical participants developing countries drugs bills sroberts overseas sroberts sroberts bills human manufacturer test researchers countries